346 related articles for article (PubMed ID: 34744006)
1. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
Medha ; Priyanka ; Sharma S; Sharma M
Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
[TBL] [Abstract][Full Text] [Related]
3. Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules.
Saraav I; Pandey K; Sharma M; Singh S; Dutta P; Bhardwaj A; Sharma S
Infect Genet Evol; 2016 Oct; 44():182-189. PubMed ID: 27389362
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.
Sayes F; Pawlik A; Frigui W; Gröschel MI; Crommelynck S; Fayolle C; Cia F; Bancroft GJ; Bottai D; Leclerc C; Brosch R; Majlessi L
PLoS Pathog; 2016 Jul; 12(7):e1005770. PubMed ID: 27467705
[TBL] [Abstract][Full Text] [Related]
5. Design of multi-epitope based vaccine against
Nayak SS; Sethi G; Ramadas K
J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
[TBL] [Abstract][Full Text] [Related]
6. Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates.
Madan R; Pandit K; Bhati L; Kumar H; Kumari N; Singh S
Microb Pathog; 2021 Aug; 157():104996. PubMed ID: 34044044
[TBL] [Abstract][Full Text] [Related]
7. Vaccine potential of ESAT-6 protein fused with consensus CD4
Choi SY; Kwon KW; Kim H; Choi HH; Shin SJ
Biochem Biophys Res Commun; 2018 Sep; 503(4):2195-2201. PubMed ID: 29894686
[TBL] [Abstract][Full Text] [Related]
8. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
[TBL] [Abstract][Full Text] [Related]
9. Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR.
Shiraz M; Lata S; Kumar P; Shankar UN; Akif M
Infect Genet Evol; 2021 Oct; 94():105017. PubMed ID: 34332157
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
[TBL] [Abstract][Full Text] [Related]
11. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
12. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
Nain Z; Karim MM; Sen MK; Adhikari UK
Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
[TBL] [Abstract][Full Text] [Related]
13. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against
Kumar A; Sharma P; Arun A; Meena LS
J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852
[TBL] [Abstract][Full Text] [Related]
14. Identification and evaluation of immunogenic MHC-I and MHC-II binding peptides from Mycobacterium tuberculosis.
Jagadeb M; Pattanaik KP; Rath SN; Sonawane A
Comput Biol Med; 2021 Mar; 130():104203. PubMed ID: 33450502
[TBL] [Abstract][Full Text] [Related]
15. Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential.
Sayes F; Sun L; Di Luca M; Simeone R; Degaiffier N; Fiette L; Esin S; Brosch R; Bottai D; Leclerc C; Majlessi L
Cell Host Microbe; 2012 Apr; 11(4):352-63. PubMed ID: 22520463
[TBL] [Abstract][Full Text] [Related]
16. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17.
Moodley A; Fatoba A; Okpeku M; Emmanuel Chiliza T; Blessing Cedric Simelane M; Pooe OJ
Immunol Res; 2022 Aug; 70(4):501-517. PubMed ID: 35554858
[TBL] [Abstract][Full Text] [Related]
17. Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines.
Medha ; Bhatt P; Priyanka ; Sharma M; Sharma S
In Silico Pharmacol; 2021; 9(1):40. PubMed ID: 34221846
[TBL] [Abstract][Full Text] [Related]
18. In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis.
Devasundaram S; Deenadayalan A; Raja A
Immunol Invest; 2014; 43(2):137-59. PubMed ID: 24467664
[TBL] [Abstract][Full Text] [Related]
19. An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis.
Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK
Appl Biochem Biotechnol; 2024 Apr; 196(4):2367-2395. PubMed ID: 37498378
[TBL] [Abstract][Full Text] [Related]
20. Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.
Liu SD; Su J; Zhang SM; Dong HP; Wang H; Luo W; Wen Q; He JC; Yang XF; Ma L
J Cell Mol Med; 2016 Sep; 20(9):1718-28. PubMed ID: 27072810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
